CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-27 | Chapman Rowan E Director | Grant or award | +271 | 8,616 | ||
| 2025-06-27 | Williams Brinkley Ruth Director | Grant or award | +2,143 | 5,107 | ||
| 2025-06-27 | ROSENMAN HERM Director | Grant or award | +2,143 | 68,205 | ||
| 2025-06-27 | ROSENMAN HERM Director | Grant or award | +271 | 68,476 | ||
| 2025-06-27 | Marcus Gail Boxer Director | Grant or award | +2,143 | 7,847 | ||
| 2025-06-27 | Marcus Gail Boxer Director | Grant or award | +271 | 8,118 | ||
| 2025-06-27 | BOTHA ROELOF Director | Grant or award | +2,143 | 6,246 | ||
| 2025-06-27 | BOTHA ROELOF Director | Grant or award | +271 | 6,517 | ||
| 2025-06-27 | Bertagnolli Monica Director | Grant or award | +2,143 | 5,020 | ||
| 2025-06-27 | Baynes Roy D. Director | Grant or award | +2,143 | 18,158 | ||
| 2025-06-20 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −7,630 | $170.63 | $1.3M | 206,044 |
| 2025-06-20 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −2,278 | $171.50 | $391K | 203,766 |
| 2025-06-18 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −10,000 | $170.18 | $1.7M | 213,674 |
| 2025-06-18 | Sheena Jonathan Director | Sale 10b5-1 | −3,070 | $167.29 | $514K | 248,774 |
| 2025-06-16 | Sheena Jonathan Director | Sale 10b5-1 | −200 | $162.50 | $32K | 38,582 |
| 2025-06-16 | Sheena Jonathan Director | Sale 10b5-1 | −203 | $163.41 | $33K | 38,379 |
| 2025-06-16 | Sheena Jonathan Director | Sale 10b5-1 | −550 | $164.81 | $91K | 37,829 |
| 2025-06-16 | Sheena Jonathan Director | Sale 10b5-1 | −547 | $165.48 | $91K | 37,282 |
| 2025-06-16 | Sheena Jonathan Director | Sale 10b5-1 | −176 | $162.52 | $29K | 38,606 |
| 2025-06-16 | Sheena Jonathan Director | Sale 10b5-1 | −200 | $163.10 | $33K | 38,406 |
Page 44 of 55 · 1,093 trades